Page last updated: 2024-11-05

triamterene and Brain Neoplasms

triamterene has been researched along with Brain Neoplasms in 1 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guillotin, D1
Austin, P1
Begum, R1
Freitas, MO1
Merve, A1
Brend, T1
Short, S1
Marino, S1
Martin, SA1

Other Studies

1 other study available for triamterene and Brain Neoplasms

ArticleYear
Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Jun-01, Volume: 23, Issue:11

    Topics: Brain Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; DNA Breaks, Double-Stranded; DNA Mismatch R

2017